This trial will test whether giving an anti-androgen agent locally to the prostate is just as effective as giving it systemically for treating prostate cancer.
- Prostate Adenocarcinoma
1 Primary · 3 Secondary · Reporting Duration: baseline versus 8 weeks post biolen implantation and 6 months post RT
1 Treatment Group
1 of 1
20 Total Participants · 1 Treatment Group
Primary Treatment: Stereotactic body radiation therapy · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 18+ · Male Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Could you provide details on other investigations that have utilized Stereotactic body radiation therapy?
"At present, 34 active clinical trials are currently investigating Stereotactic body radiation therapy with 14 of them in the final phase. Despite many being based out of Duarte, California, a total 3687 medical centres around the globe are running these studies." - Anonymous Online Contributor
Is there an ongoing enrollment process for this trial?
"Affirmative. As per the data on clinicaltrials.gov, this experiment is still actively recruiting participants since its posting date of October 1st 2021 and recent update from the same month. This trial requires 20 individuals to be sourced from one medical centre." - Anonymous Online Contributor
Has the FDA sanctioned Stereotactic body radiation therapy as an approved treatment?
"Assessed on a 1-3 scale, Stereotactic body radiation therapy has been judged as having minimal safety data with limited evidence of efficacy; it thus attained a score of 1." - Anonymous Online Contributor
How many individuals are included in the current cohort of this research trial?
"Affirmative. According to the information presented on clinicaltrials.gov, this medical trial is actively enrolling participants at the moment. It was initially posted on October 1st 2021 and edited recently on the same date. The researchers are searching for 20 individuals from a single location." - Anonymous Online Contributor
Is this research groundbreaking or has it been done before?
"Presently, 34 trials are underway for Stereotactic body radiation therapy across 849 cities in 27 countries. The inaugural trial took place back in 2000 under the aegis of AstraZeneca and included 600 patients in its Phase 3 drug approval process. In total, since that first study 74 further investigations have been conducted." - Anonymous Online Contributor